x
The Global Drug Repurposing Market was valued at USD 37.06 Billion in 2025 and is expected to reach approximately USD 51.80 Billion by 2032, registering a CAGR of 4.9% during the forecast period. The market is gaining momentum due to increasing pharmaceutical R&D costs, rising prevalence of chronic and rare diseases, growing demand for faster therapeutic development, and expanding use of artificial intelligence in drug discovery. Drug repurposing enables pharmaceutical companies to reduce development risks while accelerating the commercialization of new treatment options.
Get Full PDF Sample Copy of Report: (Including Full TOC, List )@https://www.maximizemarketresearch.com/request-sample/273130/
The drug repurposing industry is rapidly evolving through advanced computational technologies and precision medicine approaches. Key innovations include:
These technologies improve candidate identification, shorten clinical development timelines, reduce research costs, and enhance therapeutic success rates.
The Disease-Centric Approach segment continues to dominate the global market because of its ability to identify alternative therapeutic uses for approved drugs based on disease mechanisms and clinical evidence.
Its lower development risk and shorter regulatory pathway make it the preferred strategy for pharmaceutical companies.
The Oncology segment is expected to witness the fastest growth during the forecast period.
Increasing global cancer prevalence, rising investment in precision oncology, and growing adoption of combination therapies using repurposed drugs are driving significant market expansion.
North America remains the largest regional market owing to strong pharmaceutical research infrastructure, high biotechnology investments, favorable regulatory support, and widespread adoption of AI-enabled drug discovery platforms.
Asia-Pacific is projected to experience the fastest growth due to expanding pharmaceutical manufacturing, increasing clinical research activities, rising government healthcare investments, and rapid biotechnology sector development.
Major pharmaceutical companies are investing in AI-driven research, strategic collaborations, clinical trials, and precision medicine initiatives to strengthen their competitive advantage.
Get Full PDF Sample Copy of Report: (Including Full TOC, List )@https://www.maximizemarketresearch.com/request-sample/273130/
The market is driven by increasing demand for affordable drug development strategies, growing burden of chronic diseases, expanding application of AI in pharmaceutical research, and rising need to accelerate drug approval timelines.
However, regulatory complexities, intellectual property limitations, and challenges in commercial exclusivity may restrain market growth. Despite these barriers, continuous innovation in computational biology, precision medicine, and collaborative drug discovery research is expected to generate significant growth opportunities throughout the forecast period.
Get access to the full description of the report @https://www.maximizemarketresearch.com/market-report/drug-repurposing-market/273130/
Maximize Market Research Pvt. Ltd. is a globally recognized market research and consulting company providing comprehensive market intelligence across healthcare, pharmaceuticals, biotechnology, medical devices, manufacturing, chemicals, consumer goods, energy, automotive, and technology industries. Through detailed market research, strategic consulting, and competitive analysis, the company helps organizations identify emerging market opportunities, strengthen business strategies, and achieve sustainable long-term growth
